nl
02 229 52 30
Nieuwsbrief

Alles over "Risicokapitaal"

Aphea.Bio

Aphea Bio

  • Start-ups & scale-ups
  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • ESG
  • Life sciences & care

Flamingo Therapeutics

  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care
Astrivax DNA-streng

Astrivax

  • Start-ups & scale-ups
  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care

Indigo Diabetes

  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care

Investsuite

  • Start-ups & scale-ups
  • Equity investments
  • Portfolio equity investments

Lynxcare

  • Start-ups & scale-ups
  • Equity investments
  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care
biogazelle-pmv

Biogazelle

  • Start-ups & scale-ups
  • Exits Life Sciences & Care
  • Life Sciences & Care
  • Life sciences & care
  • Starten

miDiagnostics

  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care
Team Minze Health

Minze health

  • Start-ups & scale-ups
  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care
biotalys-pmv

Biotalys

  • Start-ups & scale-ups
  • Life Sciences & Care
  • Life sciences & care
Bloomlife

Bloomlife

  • Start-ups & scale-ups
  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care
Bluebee DNA

Bluebee

  • Exits Life Sciences & Care
  • Life sciences & care
Borit

Borit

  • Start-ups & scale-ups
  • Equity investments
  • Exits equity investments
Newtec

Newtec

  • Equity investments
  • Exits equity investments
  • Risicokapitaal
Nobi valdetectielamp

Nobi

  • Start-ups & scale-ups
  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care
Confo Therapeutics

Confo Therapeutics

  • Start-ups & scale-ups
  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care
novalis-fund-pmv

Novalis: gezondheidszorg in evolutie

  • Fondsen

Swave haalt 7 miljoen euro op om levensechte 3D-ervaringen naar de metaverse te brengen

28 jun 2022
  • Equity Investments
  • Risicokapitaal

Dualyx

  • Start-ups & scale-ups
  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care
teamleader-pmv

Visma neemt Teamleader over van PMV, Keen Venture Partners en Fortino Capital

23 jun 2022
  • Equity Investments
  • Risicokapitaal
lynxcare-pmv

LynxCare haalt € 20 miljoen op in Series A-investeringsronde

22 jun 2022
  • Life sciences
  • Risicokapitaal
waylay-Leonard-Donnelly-pmv

Waylay sluit Serie A-financiering af, geleid door Yokogawa, PMV en AAAF

13 jun 2022
  • Equity Investments
  • Risicokapitaal
Labo bij eTheRNA

eTheRNA

  • Start-ups & scale-ups
  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care
rein4ced-bicycle-pmv

REIN4CED zet in op groei en Vlaamse verankering met bijkomend kapitaal

12 mei 2022
  • Equity Investments
  • Risicokapitaal
1 2 3 4 5 6